Begin main content

Reports

We found 4924 result(s)

Clinical and economic considerations in the use of fluoroquinolones

Published on: January 1, 1997
Result type: Reports
Product Line: Health Technology Assessment, Technology Overviews

Cite as: Glennie JL. Clinical and economic considerations in the use of fluoroquinolones. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA); 1997. Background Fluoroquinolones (also generally referred to as "quinolones") are a class of antimicrobial drugs which, as a group, have a broad spectrum of activity against or...

Tags

Anti-Infective Agents, Ciprofloxacin, Norfloxacin, Ofloxacin, Cystitis, Drug Therapy, Cost-Benefit Analysis, Quinolones, Fluoroquinolones, Infectious Diseases, Infectious diseases, Fluoroquinolone, Bladder infections, Economic, Ciprofloxacine, Cystite, Chimiothérapie, Analyse coût bénéfice, Infections urinaires, Évaluation économique

Pain management clinics in Canada

Published on: January 1, 1997
Result type: Reports
Product Line: Other

Tags

Pain Centers, Pain Management, Pain Clinics, Outpatient Clinics, Ambulatory Care Facilities, Canada, Directory, Outpatient Clinics, Hospital, Anesthesia, Pain relief, Hospital

Extracorporeal shock wave lithotripsy (ESWL)

Published on: January 1, 1997
Result type: Reports
Product Line: Other

Tags

Lithotripsy, Extracorporeal Shockwave Lithotripsy, Electrohydraulic Shockwave Lithotripsy, Ultrasonic Lithotripsy, Noninvasive Litholapaxy, Equipment and Supplies, Hospital Equipment, Kidney Calculi, Kidney Stones, Ureteral Calculi, Ureterolithiasis, Canada, Directory, Kidney/urologic, ESWL, Hospital

Assessment of Techniques for Cervical Cancer Screening

Published on: January 1, 1997
Result type: Reports

Cite as: Noorani HZ. Assessment of techniques for cervical cancer screening. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA); 1997. Cervical cancer is one of the few readily preventable forms of cancer. Although the Papanicolaou (Pap) smear has had an enormous impact on the incidence and mortality rates of cervical...

Tags

Cervix Neoplasms, Vaginal Smears, Technology Assessment, Cancer of the Cervix, Infection, Cancer, Cancer, Papovaviridae Infections, Biomedical, Cervical cancer, Pap smears, Papanicolaou smears, Economic, Automated screening, Tumeur col utérus, Frottis vaginal, Papovaviridae, Évaluation technologie biomédicale, Cancer col utérus, Cancer du col, Test Pap, Test de Papanicolaou, Évaluation économique, Contre-dépistage automatiséPapovaviridae Infections,

An Economic Analysis of Sumatriptan for Acute Migraine

Published on: January 1, 1997
Result type: Reports
Product Line: Health Technology Assessment, Technology Overviews

Cite as: Ilersich L. An economic analysis of sumatriptan for acute migraine. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA); 1997. Background Migraine is an episodic headache that may be either a steady or throbbing pain. Episodes of migraine can vary in intensity, frequency and duration, and are often accompanied...

Tags

Migraine, Sumatriptan, Vasoconstrictor Agents, Drug Therapy, Costs and Cost Analysis, Meta-Analysis, Vasopressor Agents, Headache Disorders, Headache disorders, Metaanalysis, Economic, Vasoconstricteurs, Chimiothérapie, Coût et analyse coût, Méta-analyse, Agents vasopresseurs, Évaluation économique

Pulmozyme: Clinical and Economic Impacts

Published on: January 1, 1996
Result type: Reports
Product Line: Health Technology Assessment, Technology Overviews

Cite as: Perras C, Otten N. Pulmozyme: clinical and economic impacts. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA); 1996. Summary Remarks This overview is based on data obtained in a study commissioned by CCOHTA entitled "A Pharmacoeconomic Evaluation of DNase Use in Cystic Fibrosis" and the Phase III clinical t...

Tags

Cystic Fibrosis, Deoxyribonuclease I, Drug Therapy, Cost-Benefit Analysis, DNase, Streptodornase, Fibrocystic Disease of Pancreas, Cystic Fibrosis, CF, Pulmozyme, Economic

Use of Nitrates in Chronic Stable Angina

Published on: January 1, 1996
Result type: Reports
Product Line: Health Technology Assessment, Technology Overviews

Cite as: Perras C. The use of nitrates in chronic stable angina. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA); 1996. Nitrates are one of many agents indicated in the management of angina. For many years, isosorbide dinitrate (ISDN) was widely prescribed in the prevention and treatment of anginal attacks, but its...

Tags

Nitrates, Angina Pectoris, Drug Therapy, Angina, Angine, Cost and Cost Analysis, Economic, Nitrate, Angor, Chimiothérapie, Coût et analyse coût, Évaluation des coûts

Finasteride: Clinical and Economic Impacts

Published on: January 1, 1996
Result type: Reports
Product Line: Health Technology Assessment, Technology Overviews

Cite as: Otten N. Finasteride: clinical and economic impacts. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA); 1996. Introduction Benign prostatic hypertrophy (BPH) is the most common benign neoplasm in males. Even though microscopic evidence of BPH is evident in approximately 50% of men aged 60 and over, only 25% ...

Tags

Finasteride, Enzyme Inhibitors, Prostatic Hyperplasia, Cost-Benefit Analysis, Proscar, Kidney/urologic, Benign prostatic hypertrophy, BPH, Enlarged prostate, Economic, Anti-enzymes, Adénome prostate, Analyse coût bénéfice, Hypertrophie bénigne de la prostate, HBP, Taille de la prostate, Analyse économique

Pharmaceutical Management of Gastroesophageal Reflux Disease

Published on: January 1, 1996
Result type: Reports
Product Line: Health Technology Assessment, Technology Overviews

Cite as: Perras C, Otten N. Pharmaceutical management of gastroesophageal reflux disease. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA); 1996. Summary Remarks Heartburn and epigastric pain caused by reflux are common complaints. If bothersome, most patients self-medicate with over-the-counter medications such as ...

Tags

Gastroesophageal Reflux, Recurrence, Drug Therapy, Cost-Benefit Analysis, GERD, Relapse, Gastrointestinal Tract, Gastrointestinal tract, GORD, Economic, Reflux gastrooesophagien, Récidive, Chimiothérapie, Analyse coût bénéfice, ORGO, Reflux gastrooesophagien pathologique, Rechute, Évaluation économique